Plasmodial Sugar Transporters as Anti-Malarial Drug Targets
Author Information
Author(s): Slavic Ksenija, Krishna Sanjeev, Derbyshire Elvira T, Staines Henry M
Primary Institution: Centre for Infection, Division of Cellular and Molecular Medicine, St. George's, University of London
Hypothesis
Can the hexose transporter of Plasmodium falciparum be targeted for new anti-malarial drugs?
Conclusion
The hexose transporter PfHT has been validated as a promising drug target for treating malaria.
Supporting Evidence
- PfHT is essential for the survival of asexual blood stages of the malaria parasite.
- Compound 3361 effectively inhibits PfHT and shows potential as a new anti-malarial drug.
- PfHT has no close paralogues, making it a unique target for drug development.
Takeaway
Malaria parasites need sugar to survive, and scientists are looking at ways to block their sugar transporters to stop them from growing.
Methodology
The study involved both chemical and genetic validation of the PfHT as a drug target.
Limitations
The study primarily focuses on the PfHT and does not explore other potential drug targets in detail.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website